scanx.trade Earnings
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 99
- Sources here
- 19
- Companies here
- 8
Active search
99 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Accuray names two executives to lead transformation efforts
Accuray Incorporated has announced the appointment of Todd Brown as Senior Vice President for a new Enterprise Performance Optimization organization and Sofiane Laoussadi as Senior Vice President, Global Services & Solutions. These appointments are part of the company's "Transformation Phase II" priorities, aimed at …
Accuray (NASDAQ: ARAY) seeks approval for $55M recapitalization, dilution and reverse split
Accuray (NASDAQ: ARAY) is seeking stockholder approval for a significant financing and recapitalization plan, including issuing $55 million in Series A Convertible Preferred Stock and warrants, and a reverse stock split. The plan aims to strengthen liquidity, reduce leverage, and achieve Nasdaq compliance, but …
Is Acquiring Aurora Cannabis a Good Move for Curaleaf?
Curaleaf Holdings (OTC: CURLF) has been aggressively pursuing Canadian-based cannabis producer Aurora Cannabis (NASDAQ: ACB) for well over a month. However, that hasn't been known to investors until recently, with Curaleaf now launching a hostile takeover attempt, as it claims Aurora hasn't been responding …
Curaleaf sets sights on Aurora Cannabis
©Curaleaf to acquire Aurora Cannabis. (Source: Google Gemini. Generated by AI) In a strategic bid to forge a global cannabis powerhouse, Curaleaf Holdings (TSX:CURA) unveiled its intention to launch a takeover bid for Aurora Cannabis (TSX/NASDAQ:ACB). The proposed offer values Aurora at US$4 per …
Accuray Transfers Listing to Nasdaq Capital Market
Accuray (ARAY) has received Nasdaq approval to transfer its common stock listing from the Nasdaq Global Select Market to the Nasdaq Capital Market, effective August 6, 2026. This transfer grants the company an additional 180 days, until February 1, 2027, to meet Nasdaq's minimum …
Curanex Pharmaceuticals Inc (CURX) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Curanex Pharmaceuticals Inc (CURX), including future EPS and revenue growth estimates. It notes the current stock price, market cap, and offers an overview of the company's financial data, technical forecast, and peer comparison. The forecast data was …
Accuray Announced Transfer or Voluntary Withdrawal of Listing
Accuray (ARAY) has received Nasdaq approval to transfer its common stock listing from the Nasdaq Global Select Market to the Nasdaq Capital Market, effective August 6, 2026. The company retains its ARAY symbol and has an additional 180 days, until February 1, 2027, to …
Radiation therapy company Accuray will discuss results Aug. 19
Accuray (NASDAQ: ARAY) is scheduled to report its fourth quarter fiscal 2026 financial results on August 19, 2026, for the period ending June 30, 2026. Company management will host a conference call that day at 1:30 p.m. PT / 4:30 p.m. ET to discuss …
Neuberger Berman Group (ARAY) discloses 5.48M Accuray shares in 13G/A filing
Neuberger Berman Group LLC and its affiliates have disclosed an amended passive investment in Accuray Inc. (ARAY) via a Schedule 13G/A filing. The group beneficially owns 5,484,393 shares, representing 4.6% of Accuray’s common stock, with shared voting and dispositive power. Neuberger Berman Investment Advisers …
Accuray | SCHEDULE 13G/A: Others
This article consists solely of the title "Accuray | SCHEDULE 13G/A: Others" and the content "Document". It indicates the filing of a Schedule 13G/A, suggesting an amendment to a previous beneficial ownership report for Accuray. However, no detailed information about the filing or the …
Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026
Accuray Incorporated (ARAY) announced it will report its financial results for the fourth quarter of fiscal year 2026 on August 19, 2026. A conference call hosted by company management will take place at 1:30 p.m. PT/4:30 p.m. ET, with dial-in and webcast details provided …
Accuray Number of Employees 2026 | Employee Count & Headcount Data
Accuray, Inc. (ARAY) had 909 employees worldwide as of March 2026, representing an 8.3% decline from 2023. The company is actively hiring, with 40 active job postings in 2026, though this is a 51.9% decline from 2025. The workforce is concentrated in North America, …
Form S-3 Accuray Incorporated For: 31 July By Investing.com
This article from Investing.com announces the filing of Form S-3 by Accuray Incorporated for the period ending July 31. It is a brief administrative notice indicating a regulatory filing has been made by the company. The content primarily consists of navigational elements and market …
Price to sales forward of Accuray Incorporated – NASDAQ:ARAY
This article provides financial information for Accuray Incorporated (NASDAQ: ARAY), specifically focusing on its price to sales forward metric. It appears to be a data point or a snapshot from a financial platform like TradingView, indicating the value and change of this financial ratio. …
Curanex Pharmaceuticals Inc
This article provides a company overview for Curanex Pharmaceuticals Inc (CURX). It shows the stock price, market capitalization, and indicates that revenue breakdown data by business segment and region have not yet been disclosed by the company. The page primarily serves as a placeholder …
Accuray (ARAY) files S-3 to register 6.8M warrant shares for resale
Accuray Incorporated has filed a Form S-3 shelf registration statement to allow for the resale of up to 6,834,308 shares of common stock by certain lending investors. These shares are issuable upon the exercise of Super Premium, Premium, and Penny Warrants previously granted in …